14789-114 : Nelarabine 5 mg/ml Intravenous Injection


NDC: 14789-114
Labeler: Nexus Pharmaceuticals LLC
Product Type: Human Prescription Drug
Drug Name:  Nelarabine
Dosage Form: Intravenous Injection
Application #: ANDA215057
Rev. Date: 


Active Ingredients:

  • Nelarabine

Dosage Strength:

  • 5 mg/mL

Pharmaceutical Classes:

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 25021-259 Nelarabine 5 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 43598-142 Nelarabine 5 mg/ml Intravenous Injection by Dr. Reddy's Laboratories, Inc.
  • 68083-233 Nelarabine 5 mg/ml Intravenous Injection by Gland Pharma Limited
  • 70121-1743 Nelarabine 5 mg/ml Intravenous Injection by Amneal Pharmaceuticals LLC
  • 70710-1726 Nelarabine 5 mg/ml Intravenous Injection by Zydus Pharmaceuticals (Usa) Inc.
  • 70710-1839 Nelarabine 5 mg/ml Intravenous Injection by Zydus Pharmaceuticals USA Inc.
  • 70771-1685 Nelarabine 5 mg/ml Intravenous Injection by Cadila Healthcare Limited
  • 71288-165 Nelarabine 5 mg/ml Intravenous Injection by Meitheal Pharmaceuticals Inc
  • 80978-111 Nelarabine 250 mg/ml Intravenous Injection by Aqvida Gmbh
  • 81927-111 Nelarabine 5 mg/ml Intravenous Injection by Shorla Oncology Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 14789-114 QR Code

< Prev: 14789-110Next: 14789-115 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.